Cellular Health Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
The Global Cellular Health Screening Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing sedentary lifestyle and an aging population, consequently resulting in diseases like diabetes and obesity. Additionally, the growing adoption of telomere performance programs for maintaining a healthy life, such as maintaining a healthy weight with healthy eating, exercise regularly along with the growing importance of healthy life expectancy and the growing adoption of direct to customer approach, is expected to create significant growth during the forecasted period. Additionally, the growing geriatric population across the globe, which is susceptible to different kinds of diseases and obesity, is further expected to increase the demand for cellular health screening, thereby fuelling market growth through 2028. Besides, the growing number of cancer patients due to bad food habits across the globe, along with different chronic diseases, is increasing the demand for cellular health screening during the forecast period. This year, an estimated 66,470 people (48,520 men and 17,950 women) will be diagnosed with head and neck cancer in the United States. Similarly, an increase in research and development projects for different pre-clinical studies can make new drugs or supplements enhance the demand for the cellular health screening market in the forecast period.
The growing Prevalence of Chronic Diseases is Driving the Market’s Growth.
Increasing adoption of telomere performance programs is expected to create lucrative growth for the global cellular health screening market during the forecast period. Due to the increasing prevalence of chronic diseases, the demand for leading a healthy lifestyle has increased, which is further expected to drive market growth over the years. Around 46% of all diseases worldwide and 60% of the 56.5 million deaths in 2001 were due to chronic conditions. Different factors are responsible for changes in cellular aging, such as physical activity, sleep, and psychological disorders. Also, excessive smoking and drinking habits can create different types of chronic diseases, which will further demand cellular health screening. The usage of telomere tests provides clinicians with insights into metabolic and genetic diseases with early diagnosis and timely personalized treatment plans for patients. However, growing awareness and research about cellular screening have led to a rise in the demand for kit tests, which is further expected to boost the market growth during the forecast period. According to the National Cancer Institute, in 2018, there were 1,735,350 new cancer cases diagnosed in the United States.
Increasing Geriatric Population Propelling the Market Growth
The increasing prevalence rate of lifestyle disorders such as diabetes and obesity, excessive alcohol consumption, tobacco use, low physical activity, high body mass index, and low intake of fruits and vegetables because of a growing population is further expected to create a lucrative growth of the market during the forecast period. The growing geriatric population and its consequent growth are expected to raise the demand for cellular health screening, in turn propelling the growth of the market. In 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the United States, and 606,520 people died from the disease.
Market Segmentation
The global cellular health screening market can be segmented by test type, sample, site of collection, and by region. Based on test type, the market can be divided into Single Test Panels v/s Multi Test Panels. Based on the sample, the market can be segmented into Blood, Saliva, Urine, and Others. Based on the site of collection, the market can be differentiated into homes, Hospitals & Clinics, Diagnostic Laboratories, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global cellular health screening market on account of the growing demand for maintaining healthy life expectancy, along with the growing adoption of new technology in the country.
Market Players
Telomere Diagnostics, Inc., Quest Diagnostics, Inc., Laboratory Corporation of America Holdings, SpectraCell Laboratories, Inc., Cell Science Systems Corporation, Immundiagnostik AG, Repeat Diagnostics, Inc., OPKO Health, Inc., Genova Diagnostics, Inc., Titanovo, Inc. are some of the leading players operating in the Global Cellular Health Screening Market.
Recent Development
- For instance, Lab Corp announced in April 2022 that it has launched a home collection service for various diagnostic and screening test offerings of the company.
- For example, in September 2020, Genova Diagnostics partnered with Rocky Mountain Analytical, a subsidiary of LifeLabs. The partnership allowed greater accessibility of Genova’s tests for Canadian patients and clinics.
In this report, global cellular health screening systems market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Cellular Health Screening Market, By Test Type:
- Single Test Panels
- Multi-Test Panels
- Cellular Health Screening Market, By Sample:
- Blood
- Saliva
- Urine
- Others
- Cellular Health Screening Market, By Site of Collection:
- Home
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
- Cellular Health Screening Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in Global Cellular Health Screening Market.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
- 1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
- 2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
- 3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
- 4. Voice of Customer
- 5. Global Cellular Health Screening Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Test Type (Single Test Panels v/s Multi Test Panels)
- 5.2.2. By Sample (Blood, Saliva, Urine, Others)
- 5.2.3. By Site of Collection (Home, Hospitals & Clinics, Diagnostic Laboratories, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2022)
- 5.3. Market Map
- 5.3.1. By Test Type
- 5.3.2. By Sample
- 5.3.3. By Site of Collection
- 5.3.4. By Region
- 6. North America Cellular Health Screening Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Test Type
- 6.2.2. By Sample
- 6.2.3. By Site of Collection
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Cellular Health Screening Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Test Type
- 6.3.1.2.2. By Sample
- 6.3.1.2.3. By Site of Collection
- 6.3.2. Canada Cellular Health Screening Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Test Type
- 6.3.2.2.2. By Sample
- 6.3.2.2.3. By Site of Collection
- 6.3.3. Mexico Cellular Health Screening Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Test Type
- 6.3.3.2.2. By Sample
- 6.3.3.2.3. By Site of Collection
- 7. Europe Cellular Health Screening Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Test Type
- 7.2.2. By Sample
- 7.2.3. By Site of Collection
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Cellular Health Screening Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Test Type
- 7.3.1.2.2. By Sample
- 7.3.1.2.3. By Site of Collection
- 7.3.2. Germany Cellular Health Screening Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Test Type
- 7.3.2.2.2. By Sample
- 7.3.2.2.3. By Site of Collection
- 7.3.3. United Kingdom Cellular Health Screening Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Test Type
- 7.3.3.2.2. By Sample
- 7.3.3.2.3. By Site of Collection
- 7.3.4. Italy Cellular Health Screening Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Test Type
- 7.3.4.2.2. By Sample
- 7.3.4.2.3. By Site of Collection
- 7.3.5. Spain Cellular Health Screening Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Test Type
- 7.3.5.2.2. By Sample
- 7.3.5.2.3. By Site of Collection
- 8. Asia-Pacific Cellular Health Screening Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Test Type
- 8.2.2. By Sample
- 8.2.3. By Site of Collection
- 8.2.4. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Cellular Health Screening Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Test Type
- 8.3.1.2.2. By Sample
- 8.3.1.2.3. By Site of Collection
- 8.3.2. India Cellular Health Screening Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Test Type
- 8.3.2.2.2. By Sample
- 8.3.2.2.3. By Site of Collection
- 8.3.3. Japan Cellular Health Screening Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Test Type
- 8.3.3.2.2. By Sample
- 8.3.3.2.3. By Site of Collection
- 8.3.4. South Korea Cellular Health Screening Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Test Type
- 8.3.4.2.2. By Sample
- 8.3.4.2.3. By Site of Collection
- 8.3.5. Australia Cellular Health Screening Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Test Type
- 8.3.5.2.2. By Sample
- 8.3.5.2.3. By Site of Collection
- 9. South America Cellular Health Screening Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Test Type
- 9.2.2. By Sample
- 9.2.3. By Site of Collection
- 9.2.4. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Cellular Health Screening Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Test Type
- 9.3.1.2.2. By Sample
- 9.3.1.2.3. By Site of Collection
- 9.3.2. Argentina Cellular Health Screening Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Test Type
- 9.3.2.2.2. By Sample
- 9.3.2.2.3. By Site of Collection
- 9.3.3. Colombia Cellular Health Screening Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Test Type
- 9.3.3.2.2. By Sample
- 9.3.3.2.3. By Site of Collection
- 10. Middle East and Africa Cellular Health Screening Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Test Type
- 10.2.2. By Sample
- 10.2.3. By Site of Collection
- 10.2.4. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Cellular Health Screening Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Test Type
- 10.3.1.2.2. By Sample
- 10.3.1.2.3. By Site of Collection
- 10.3.2. Saudi Arabia Cellular Health Screening Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Test Type
- 10.3.2.2.2. By Sample
- 10.3.2.2.3. By Site of Collection
- 10.3.3. UAE Cellular Health Screening Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Test Type
- 10.3.3.2.2. By Sample
- 10.3.3.2.3. By Site of Collection
- 11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
- 12. Market Trends & Developments
- 12.1. Recent Developments
- 12.2. Mergers & Acquisitions
- 12.3. Product Launches
- 13. Competitive Landscape
- 13.1. Business Overview
- 13.2. Product Offerings
- 13.3. Recent Developments
- 13.4. Financials (As Reported)
- 13.5. Key Personnel
- 13.6. SWOT Analysis
- 13.6.1. Telomere Diagnostics, Inc.
- 13.6.2. Quest Diagnostics, Inc.
- 13.6.3. Laboratory Corporation of America Holdings
- 13.6.4. SpectraCell Laboratories, Inc.
- 13.6.5. Cell Science Systems Corporation
- 13.6.6. Immundiagnostik AG
- 13.6.7. Repeat Diagnostics, Inc.
- 13.6.8. OPKO Health, Inc.
- 13.6.9. Genova Diagnostics, Inc.
- 13.6.10. Titanovo, Inc.
- 14. Strategic Recommendations
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook